A Randomized Direct Comparison of the Pharmacokinetics and Pharmacodynamics of Apixaban and Rivaroxaban [Corrigendum]

Clinical Pharmacology: Advances and Applications - New Zealand
doi 10.2147/cpaa.s168295
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Informa UK Limited

Related search

Safety, Pharmacokinetics and Pharmacodynamics of Single Doses of Rivaroxaban – An Oral, Direct Factor Xa Inhibitor – In Elderly Chinese Subjects

Thrombosis and Haemostasis
Hematology
2010English

Rivaroxaban and Apixaban in Orthopaedics

Blood Coagulation and Fibrinolysis
MedicineHematology
2015English

Pharmacokinetics and Pharmacodynamics of Suxamethonium

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
1997English

The Pharmacokinetics and the Pharmacodynamics of Cannabinoids

British Journal of Clinical Pharmacology
Pharmacology
2018English

Journal of Pharmacokinetics and Pharmacodynamics

Journal of Pharmacokinetics and Pharmacodynamics
Pharmacology
English

Effect of Famotidine on the Pharmacokinetics of Apixaban, an Oral Direct Factor Xa Inhibitor

Clinical Pharmacology: Advances and Applications
Pharmacology
2013English

Pharmacoeconomic Analysis of Dabigatran in Patients With Atrial Fibrillation: Comparison With Rivaroxaban or Apixaban

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2014English

A Comparison of the Pharmacokinetics and Pharmacodynamics of Docetaxel Between African-American and Caucasian Cancer Patients: CALGB 9871

Clinical Cancer Research
Cancer ResearchOncology
2007English

Transportan 10 Improves the Pharmacokinetics and Pharmacodynamics of Vancomycin

Scientific Reports
Multidisciplinary
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy